2006
DOI: 10.1016/j.jneuroim.2006.08.013
|View full text |Cite
|
Sign up to set email alerts
|

MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
21
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(23 citation statements)
references
References 51 publications
1
21
1
Order By: Relevance
“…As to the wide distribution of VCAM-1 in human tissues and organs, this molecule is implicated in a plenty of pathophysiological situations, which include autoimmune diseases [31], cardiovascular disease [32], or infections [33]. Recently, its function in tumor progression and metastasis has drawn increasing attentions.…”
Section: Discussionmentioning
confidence: 99%
“…As to the wide distribution of VCAM-1 in human tissues and organs, this molecule is implicated in a plenty of pathophysiological situations, which include autoimmune diseases [31], cardiovascular disease [32], or infections [33]. Recently, its function in tumor progression and metastasis has drawn increasing attentions.…”
Section: Discussionmentioning
confidence: 99%
“…MMP levels are increased in MS (Anthony et al, 1997;Cossins et al, 1997;Gijbels et al, 1992;Maeda and Sobel, 1996;Ozenci et al, 2000;Ozenci et al, 1999;Rosenberg et al, 1996;Sellebjerg et al, 2000;Trojano et al, 1999;Waubant et al, 1999) and in animal models of MS including experimental allergic encephalomyelitis (EAE) Gijbels et al, 1993;Graesser et al, 1998;Graesser et al, 2000;Jovanova-Nesic and Shoenfeld, 2006;Kieseier et al, 1998;Teesalu et al, 2001), and are very closely linked to pathogenesis and disease progression. Elevated serum MMP activity is detectable extremely early in the disease course, being present even in prodromal phases prior to development of clinically diagnosed MS (Correale and Bassani Molinas Mde, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…In contrast to non-CNS barriers that constitutively express high levels of both adhesion molecules VCAM-1 and ICAM-1 (Steffen, Breier, Butecher, Schultz, & Engelhardt, 1996;Hofman et al, 2002), we and others have shown that brain-derived endothelial cells (Brown, McFarlin, & Raine, 1991;Jovanova-Nesic, & Shoenfeld, 2006) have reduced levels of expression of these molecules under basal conditions (Wolburg, Gerhardt, Schulz, Wolburg, & Engelhardt, 2004), and represent a less permissive barrier to cell migration comparing to that high endothelial venules (HUVECs) in the periphery (Wong, Prameya, & Dorovini-Zis, 1999).…”
Section: Introductionmentioning
confidence: 60%
“…The mechanisms of CSF secretion by CP (Speake et al, 2001), and the role of CP in CSF homeostasis and brain viability becomes more evident when the system fails (Johanson, Silverberg, Donahue, & Stopa, 2005). Thus, limited number of endothelial cells and increased expression of VCAM-1 + immunoreactivity in the choroids plexus in acute EAE (Jovanova-Nesic, & Shoenfeld, 2006) shows emerging importance of the choroids plexus epithelial system in EAE induction. Detailed analysis of epithelial cell expression of adhesive molecules and matrix metalloproteinases (MMPs) are necessary to evaluate how diminished choroidal functions affect the surrounding brain in the face of EAE, and multiple sclerosis (Sobel, 1998).…”
Section: Introductionmentioning
confidence: 99%